CASI Pharmaceuticals, Inc.
CASI News Today: Stay Updated with the Latest CASI Pharmaceuticals, Inc. News in Real Time
Find CASI news now at Meyka AI. Stay informed with the latest CASI Pharmaceuticals, Inc. stocks updates, including price news, market analysis, and expert insights.
PATH (UiPath, NYSE) closes at $10.10 on 26 Feb 2026: AI pivot tests valuation
PATH stock: UiPath closes $10.10 on 26 Feb 2026, Meyka AI outlook and forecast
Barclays Maintains Overweight on C4 Therapeutics (CCCC) Feb 26, 2026
Barclays and Cowen maintain ratings on C4 Therapeutics. Read Feb 26, 2026 CCCC analyst rating and implications
NWTT stock: NW Tech Capital (NWTT) PNK trades at $0.00010 in US market hours 26 Feb 2026: watch liquidity and downside
NWTT stock trades at $0.00010 on PNK 26 Feb 2026. Meyka AI grade B, HOLD; model projects -84.21% vs current price
Bank of America Maintains Buy on eBay Inc. (EBAY) Feb 26, 2026
Bank of America keeps Buy on eBay. Read the latest EBAY analyst rating, market reaction, and Meyka grade B+
Up 33.33% today: BURY.CN Burrell Resources Inc. (CNQ) 26 Feb 2026: Antelope option fuels momentum
BURY.CN stock jumps 33.33% to C$0.14 on Feb 26, 2026; we review catalysts, valuation and Meyka AI forecast
Leerink Maintains Outperform on Vir Biotechnology, Inc. (VIR) Feb 2026
Leerink keeps Outperform and raises PT to $20. VIR analyst rating update and implications for investors
SU.TO Suncor Energy (TSX) C$75.91 after-hours 26 Feb 2026: volume hints upside
SU.TO stock trades C$75.91 after-hours on 26 Feb 2026 with heavy volume; we assess valuation, technicals and a C$86.46 five-year forecast
Leerink Maintains Outperform on Certara, Inc. (CERT) Feb 26 2026 PT $10
CERT analyst rating: Leerink keeps Outperform on Certara, Inc. and cuts PT to $10 on Feb 26 2026
Leerink Maintains Outperform on GoodRx (GDRX) Feb 26, 2026 PT $3
Leerink maintains Outperform on GoodRx. GDRX analyst rating cut PT to $3; implications and Meyka grade B+